CYPRESS BIOSCIENCE, INC. – Trademark Portfolio
Entity Type: 03
CYPRESS BIOSCIENCE, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AVISE. The owner is based in SAN DIEGO, CA.
4350 EXECUTIVE DRIVE, #325
SAN DIEGO, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
CYPRESS BIOSCIENCE, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CYPRESS BIOSCIENCE, INC. have?
CYPRESS BIOSCIENCE, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned, 7 cancelled.
What trademark classes does CYPRESS BIOSCIENCE, INC. file in?
CYPRESS BIOSCIENCE, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CYPRESS BIOSCIENCE, INC.'s most well-known trademarks?
CYPRESS BIOSCIENCE, INC.'s registered trademark portfolio includes well-known marks such as AVISE. These are among 1 currently registered trademark in the portfolio.
What is CYPRESS BIOSCIENCE, INC.'s trademark registration success rate?
CYPRESS BIOSCIENCE, INC. has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.